Prolactin: Pituitary Output Under Dopamine's Brake
Prolactin blood testing measures the level of prolactin, a protein hormone (polypeptide) made mainly in the front part of the pituitary gland (anterior pituitary) by lactotroph cells. Its release is normally held back by signals from the brain's dopamine system (hypothalamic dopamine). Prolactin naturally rises in pregnancy, after childbirth, with nipple stimulation, and during sleep.
Prolactin's core job is to start and sustain milk production (lactation) and support breast development (mammary gland maturation). It also shapes the reproductive hormone network by dialing down the brain signal that triggers ovulation and sperm/testosterone production (suppression of GnRH, with downstream effects on LH and FSH). Because of this, prolactin influences menstrual cycles, fertility, and sexual function in all sexes. It also has roles in stress and immune signaling. A prolactin test therefore reflects how active the pituitary's prolactin system is and how well the brain's dopamine "brake" is working, offering a window into lactation biology and the broader reproductive hormone axis.
Why Prolactin Sits at the Crossroads of Pituitary and Reproduction
Prolactin is a pituitary hormone that links the brain's signals to reproduction, breast development, and milk production. It also modulates stress responses and immune activity. A prolactin blood test therefore gives a window into pituitary health and the reproductive axis, with ripple effects on menstrual cycles, fertility, sexual function, bone health, and mood.
From Low Lactotroph Activity to Adenoma-Driven Highs
In adults not pregnant or breastfeeding, typical values sit in the low double digits (men often about 5–15; nonpregnant women about 5–25). The healthiest values tend to be in the lower-to-middle part of that range. Levels naturally rise with sleep, stress, sex, and some medicines, and are much higher in pregnancy and lactation.
When prolactin is low, it usually reflects reduced pituitary lactotroph activity or strong dopamine inhibition. Most people feel little, but after childbirth it can cause poor milk production. Because low prolactin can travel with other pituitary hormone deficits, there may be fatigue, low libido, or low blood pressure from accompanying adrenal or thyroid insufficiency.
When prolactin is high, the dopamine "brake" is lifted—by a prolactin-secreting pituitary adenoma, hypothyroidism, kidney or liver disease, or medications that block dopamine. Elevated prolactin suppresses GnRH, lowering estrogen or testosterone: women may have irregular or absent periods, infertility, vaginal dryness, or milk discharge; men may have low libido, erectile dysfunction, reduced body hair growth, and occasionally galactorrhea. Large pituitary tumors can cause headaches or vision changes. In teens, sustained elevation can delay puberty.
Being in range suggests stable hypothalamic-pituitary control with balanced dopaminergic inhibition and normal feedback across the reproductive axis. In nonpregnant adults tested in the morning, optimal tends to sit in the low-to-mid portion of the reference interval, consistent with normal sex hormone production and bone maintenance.
Sleep, Stress, Medications, and Assay Quirks
Prolactin rises with sleep, stress, recent exercise, and nipple stimulation; morning, fasting sampling reduces variability. Pregnancy and lactation require separate ranges. Assays can be confounded by macroprolactin (biologically inactive) and the "hook effect" in very high tumors. Dopamine agonists lower results; estrogens, opioids, and antipsychotics raise them.
Reading Prolactin With TSH and Sex Steroids
Big picture, prolactin sits at the crossroads of the hypothalamic–pituitary–gonadal and thyroid systems. Persistently abnormal levels influence fertility, bone density, and wellbeing, making this test a key clue to endocrine balance and long-term health.
What Prolactin Reveals About Pituitary and Reproductive Health
Prolactin is a pituitary hormone mainly known for enabling lactation, but it also modulates the reproductive axis, stress responses, immune signaling, and energy balance. The test reflects pituitary lactotroph output under hypothalamic control—dopamine restrains prolactin, while estrogen and TRH stimulate it—so results give a window into pituitary-hypothalamic integration and the downstream effects on sex hormones, bone, mood, and metabolism.
FAQs
A blood test that measures prolactin concentration to assess pituitary function and its influence on reproductive and thyroid health.
Testing helps explain irregular periods, infertility, low libido, erectile issues, nipple discharge, and low milk supply, and it supports monitoring medication or thyroid effects.
Start with a baseline, then retest after treatment, medication changes, or symptom shifts. Many people retest within 4–12 weeks or at intervals suggested by their clinician.
Time of day, stress, sleep, sexual activity, nipple stimulation, exercise, pregnancy, breastfeeding, medications, thyroid function, kidney or liver disease, and chest wall stimulation.
Yes. Test in the morning 3–4 hours after waking, rest beforehand, and avoid recent intense exercise, sexual activity, or nipple stimulation.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Chasseloup, F., Bernard, V., & Chanson, P. (2024). Prolactin: structure, receptors, and functions. Reviews in Endocrine & Metabolic Disorders, 25(6), 953-966. https://doi.org/10.1007/s11154-024-09915-8
- Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. (2011). Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 96(2), 273-288. https://doi.org/10.1210/jc.2010-1692
- Fahie-Wilson, M. N., Cobbaert, C. M., Horvath, A. R., & Smith, T. P. (2022). Interference by macroprolactin in assays for prolactin: Will the In Vitro Diagnostics Regulation lead to a solution at last? Clinical Chemistry and Laboratory Medicine, 60(9), 1350-1355. https://doi.org/10.1515/cclm-2022-0460
- Köhrle, J. (2018). Thyroid hormones and derivatives: Endogenous thyroid hormones and their targets. Methods in Molecular Biology, 1801, 85-104. https://doi.org/10.1007/978-1-4939-7902-8_9
- Vilar, L., Vilar, C. F., Lyra, R., & Freitas, M. C. (2019). Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology, 109(1), 7-19. https://doi.org/10.1159/000499694






































.avif)
